+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Matrix metalloproteinases and tumor progression

Matrix metalloproteinases and tumor progression

Advances in Experimental Medicine and Biology 532: 91

The matrix metalloproteinases (MMPs) are a family of more than 20 distinct enzymes that are frequently overexpressed in human tumors. Functional studies have shown that MMPs play an important role in the proteolytic destruction of extracellular matrix and basement membranes, thereby facilitating tumor invasion and metastasis. In addition, these enzymes may also be important in other steps of tumor evolution including neoplastic cell proliferation and angiogenesis stimulation. On the basis of the relevance of MMPs in tumor progression, a number of different strategies aimed to block the unwanted activity of these enzymes in cancer have been developed. Unfortunately, most clinical trials with the first series of MMP inhibitors have failed to show clear benefit in patients with advanced cancer. Explanations for this lack of success include the failure to recognize the role of these enzymes in early stages of the disease as well as inadequacy of either the employed inhibitors or the proteases to be targeted. The introduction of novel concepts such as tumor degradome, and global approaches to protease analysis, may facilitate the identification of the relevant MMPs that must be targeted in each individual cancer patient. On the other hand, the finding that MMPs are enzymes whose effects on biologically active substrates can have profound consequences on cell behaviour, suggests that selective inhibition of a limited set of MMPs at early stages of tumor evolution might be much more effective than using wide-spectrum inhibitors active against most family members, and administered to patients at late stages of the disease. Further studies directed to elucidate these questions will be necessary to clarify whether any of the multiple strategies of MMP inhibition may be part of future therapeutic approaches to control tumor progression.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 049538283

Download citation: RISBibTeXText

PMID: 12908552

Related references

The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Turkish Journal of Gastroenterology 20(1): 41-47, 2009

Matrix metalloproteinases in tumor progression. Proceedings of the American Association for Cancer Research Annual Meeting 40: 769-770, 1999

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Reviews 14(4): 351-362, 1995

Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion and Metastasis 14(1-6): 234-245, 1994

Regulation of tumor progression of EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. FASEB Journal 14(4): A540, 2000

Matrix-degrading metalloproteinases in tumor progression. Princess Takamatsu Symposia 24: 152-161, 1994

Matrix metalloproteinases and their inhibitors in tumor progression. Annals of the new York Academy of Sciences 732: 222-232, 1994

Matrix metalloproteinases: promoters of tumor progression and invasiveness. Israel Medical Association Journal 4(4): 280-282, 2002

Matrix metalloproteinases: Multifunctional contributors to tumor progression. Molecular Medicine Today 6(4): 149-156, 2000

Complex roles of matrix metalloproteinases in tumor progression. Current Topics in Microbiology and Immunology 213: 1-21, 1996

Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87(3-4): 329-342, 2005

The role of matrix metalloproteinases in intestinal tumor progression. Clinical & Experimental Metastasis 14(Suppl. 1): 59-60, 1996

Matrix metalloproteinases and inhibitors Changing roles in tumor progression. FASEB Journal 15(5): A744, 2001

The fibrinolytic system and matrix metalloproteinases in angiogenesis and tumor progression. Seminars in Thrombosis and Hemostasis 30(1): 71-82, 2004

Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression. International Journal of Gynecological Cancer 16(3): 1297-1302, 2006